EcoDrugPlus

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSOKIG00005018005
Gene Symbol: LOC109868044
3 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2

Ensembl ID : ENSOKIG00005013836
Gene Symbol: LOC109865644
3 Cross references
202 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSOKIG00005048607
Gene Symbol: PDPK1
3 Cross references
215 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSOKIG00005022818
Gene Symbol: PDPK1A
1 Cross references
165 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSOKIG00005015549
Gene Symbol: PDPK1A
1 Cross references
165 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSOKIG00005022926
Gene Symbol: LOC109865474
3 Cross references
214 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSOKIG00005028222
Gene Symbol: HPD
3 Cross references
198 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSOKIG00005000347
Gene Symbol: LOC109873492
3 Cross references
198 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSOKIG00005003780
Gene Symbol: LOC109888442
3 Cross references
55 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSOKIG00005013416
Gene Symbol: LOC109888442
3 Cross references
55 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSOKIG00005039896
Gene Symbol: LOC109872787
3 Cross references
45 Possible Orthologues:

40s Ribosomal Protein S15

Ensembl ID : ENSOKIG00005032599
Gene Symbol: LOC109875002
3 Cross references
288 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).